RANK 11
Revenue 106.70 Crore
|
RFCL |
MD: Mr Sushil Mehta
|
Business: Manufacturing and
marketing of fine chemicals and lab kits |
Start-up Year: 2005
|
Address: A-3, Okhla Industrial area,
Phase-I, New Delhi-110020
Tel: +91-11-41609171 / 75
Fax: +91-11-41609189
Website: www.rfcl.in |
RFCL, which has been acquired by
US-based
Avantor, is expected to leverage the experience of its new mentor to
improve its products
![](/IMG/279/46279/12sushilmehtamdrfcl.jpg)
RFCL, formerly known as Ranbaxy Fine Chemicals
Limited, is a maker of laboratory reagents, consumables and products
for the medical diagnostics’ market. The company is now a part of
US-based Avantor Performance Materials Holdings, which is involved in
manufacturing and marketing high-performance chemicals and materials.
The acquisition took place following the exit of the previous owner,
ICICI Venture Funds Management Company. Avantor can use the
RFCL’s network in India to push its products in the market. During the
FY 2010-11, the company recorded revenue worth
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
106.7 crore as compared
to
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
93.23 crore in FY 2009-10.
The company is managed by a group of professionals and it focuses
primarily on two strategic business units – Rankem Scientific
Laboratory Solutions and Diagnova. The two business segments cover a
range of customer segments including pharmaceuticals, biotechnology,
R&D laboratories, food processing, in vitro diagnostic facilities
in clinical labs, hospitals and nursing homes. Together, the two
business units constitute a business group of approximately
![](http://www.biospectrumindia.com/images/content/2010/aug/INR-currency_symbol.jpg)
2,400
million.
Driven by its vision, ‘Leveraging Science to Provide Solutions for a
Better Life’, RFCL is aggressively building both its businesses backed
by R&D, product development and manufacturing, to offer value added
products and services to its target customers. The company in 2010
unveiled its new mid-term plan called ‘SPRINT 2014’, which it expects
to enable RFCL to grow at a CAGR of almost 23 percent in the next
four years. RFCL added 64 products to its portfolio. In molecular
biology, an additional 47 products will be completing the basket of
fermentation area where the purity and accuracy is now defined at
upstream process.
In July 2010, RFCL inked a technology transfer partnership with Diagon,
Hungary, for Haematology reagents. Also, a new lab chemical
manufacturing plant of the company is coming up at Panoli, Gujarat.